Caroline K. Fong

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Maintenance capecitabine after first-line platinum-based chemotherapy in advanced oesophagogastric adenocarcinoma: final analysis from the PLATFORM trial.

Maintenance capecitabine after first-line platinum-based chemotherapy in advanced oesophagogastric adenocarcinoma: final analysis from the PLATFORM trial.

Journal: British journal of cancer

Published: December 17, 2025

Maintenance Capecitabine Plus Ramucirumab After First-Line Chemotherapy in Patients With Advanced Esophagogastric Adenocarcinoma: Results From the Randomized PLATFORM Study.

Maintenance Capecitabine Plus Ramucirumab After First-Line Chemotherapy in Patients With Advanced Esophagogastric Adenocarcinoma: Results From the Randomized PLATFORM Study.

Journal: JCO oncology advances

Published: September 18, 2024

MicroRNAs as biomarkers for trastuzumab-based therapy in HER2-positive advanced oesophago-gastric cancer patients.

MicroRNAs as biomarkers for trastuzumab-based therapy in HER2-positive advanced oesophago-gastric cancer patients.

Journal: Frontiers in oncology

Published: July 13, 2023

Genetic and immune landscape evolution in MMR-deficient colorectal cancer.

Genetic and immune landscape evolution in MMR-deficient colorectal cancer.

Journal: The Journal of pathology

Published: June 23, 2023

Targeted Therapies and Developing Precision Medicine in Gastric Cancer.

Targeted Therapies and Developing Precision Medicine in Gastric Cancer.

Journal: Cancers

Published: April 23, 2023

Impact of pharmacogenomic DPYD variant guided dosing on toxicity in patients receiving fluoropyrimidines for gastrointestinal cancers in a high-volume tertiary centre.

Impact of pharmacogenomic DPYD variant guided dosing on toxicity in patients receiving fluoropyrimidines for gastrointestinal cancers in a high-volume tertiary centre.

Journal: BMC cancer

Published: January 11, 2023

Neoadjuvant and Adjuvant Therapy Approaches to Gastric Cancer.

Neoadjuvant and Adjuvant Therapy Approaches to Gastric Cancer.

Journal: Current treatment options in oncology

Published: July 14, 2022

HER2 Inhibition in Gastric Cancer-Novel Therapeutic Approaches for an Established Target.

HER2 Inhibition in Gastric Cancer-Novel Therapeutic Approaches for an Established Target.

Journal: Cancers

Published: June 24, 2022

Activity and toxicity of intramuscular 1000 iu/m2 polyethylene glycol-E. coli L-asparaginase in the UKALL 2003 and UKALL 2011 clinical trials.

Activity and toxicity of intramuscular 1000 iu/m2 polyethylene glycol-E. coli L-asparaginase in the UKALL 2003 and UKALL 2011 clinical trials.

Journal: British journal of haematology

Published: December 28, 2021

Chemotherapy with nivolumab in advanced gastro-oesophageal adenocarcinoma.

Chemotherapy with nivolumab in advanced gastro-oesophageal adenocarcinoma.

Journal: Lancet (London, England)

Published: April 08, 2021

Broadening the therapeutic horizon of advanced biliary tract cancer through molecular characterisation.

Broadening the therapeutic horizon of advanced biliary tract cancer through molecular characterisation.

Journal: Cancer treatment reviews

Published: January 02, 2020

Up-to-Date Tailored Systemic Treatment in Pancreatic Ductal Adenocarcinoma.

Up-to-Date Tailored Systemic Treatment in Pancreatic Ductal Adenocarcinoma.

Journal: Gastroenterology research and practice

Published: May 30, 2019

Showing 1-12 of 12

Last Updated: 09/26/2026